Fitbit begins smartwatch blood pressure tracking study

Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to...

UroMems Completes €23 Million Series B Financing

Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from...

Pixium Puts Second Sight in Rear View with Pivotal Trial

Pixium’s PRIMAvera study is an open-label, baseline-controlled, nonrandomized, multi-center, prospective, single-arm confirmatory trial of the Prima System. The implant is a bionic vision system...

Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain

Nevro touted results from a trial of its Senza system for treating painful diabetic neuropathy (PDN)-related chronic pain. Redwood City, Calif.-based Nevro, which published the...

Full results of EndeavorRx adjunct trial show longer benefits with or without stimulant therapy

The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer. Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial....

Ava to commence trial of fertility tracker device for Covid-19 detection

Ava, a digital healthcare company that focuses on women's reproductive health, has announced it will be launching the first study of its kind to test...

Insulet’s Omnipod 5 trial shows benefits across patient groups with Type 1 diabetes

Clinical trial results for Insulet's Omnipod 5 automated insulin pump system showed improvements across multiple metrics after three months of use for adult, adolescent and pediatric...

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan® , the first and only patient-friendly, preparation-free, screening test to detect polyps...

BrainQ announces encouraging study results for new therapy to reduce disability after stroke

Study presented 77% of the treatment group recovered to a level of no symptoms or no significant disability on the modified Rankin Scale BrainQ, the...

Latest articles